Davis, Susan Supplementary data-Intra-vaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors. 2018.pdf This table reports the clinician reported assessment outcomes for intra-vaginal testosterone vs placebo over 26 weeks in women taking an aromatase inhibitor testosterone;intra-vaginal;vulvo-vginal atrophy;breast cancer;Endocrinology 2018-08-04
    https://bridges.monash.edu/articles/dataset/Supplementary_data-Intra-vaginal_testosterone_improves_sexual_satisfaction_and_vaginal_symptoms_associated_with_aromatase_inhibitors_2018_pdf/6933176
10.26180/5b6517ab522f4